» Authors » Ingrid Hansen-Pupp

Ingrid Hansen-Pupp

Explore the profile of Ingrid Hansen-Pupp including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 42
Citations 939
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Ley D, Hallberg B, Hansen-Pupp I, Dani C, Ramenghi L, Marlow N, et al.
J Pediatr . 2018 Nov; 206:56-65.e8. PMID: 30471715
Objective: To investigate recombinant human insulin-like growth factor 1 complexed with its binding protein (rhIGF-1/rhIGFBP-3) for the prevention of retinopathy of prematurity (ROP) and other complications of prematurity among extremely...
22.
Hagman C, Bjorklund L, Hellgren G, Tufvesson E, Hansen-Pupp I
Pediatr Pulmonol . 2018 Jul; 53(10):1399-1406. PMID: 29992757
Background: Club cell secretory protein (CC16) probably has a role in protecting the lung from inflammation. Aim: To evaluate if low levels of CC16 in gastric fluid at birth, reflecting...
23.
Zamir I, Tornevi A, Abrahamsson T, Ahlsson F, Engstrom E, Hallberg B, et al.
J Pediatr . 2018 May; 200:104-110.e1. PMID: 29731360
Objective: To explore the prevalence of hyperglycemia and the associations between nutritional intakes, hyperglycemia, insulin treatment, and mortality in extremely preterm infants. Study Design: Prospectively collected data from the Extremely...
24.
Hellgren G, Lofqvist C, Hansen-Pupp I, Gram M, Smith L, Ley D, et al.
Growth Horm IGF Res . 2017 Dec; 39:19-24. PMID: 29274846
Objective: Retinopathy of prematurity (ROP) is a multifactorial disease linked to low insulin-like growth factor (IGF)-I levels and perhaps to postnatal inflammation. Here, we investigated the longitudinal postnatal serum concentrations...
25.
Hellstrom A, Ley D, Hallberg B, Lofqvist C, Hansen-Pupp I, Ramenghi L, et al.
Curr Pharm Des . 2017 Oct; 23(38):5964-5970. PMID: 28969546
Background: Insulin-like growth factor 1 (IGF-1) is a mitogenic hormone involved in many processes such as growth, metabolism, angiogenesis and differentiation. After very preterm birth, energy demands increase while maternal...
26.
Hansen-Pupp I, Hellstrom A, Hamdani M, Tocoian A, Kreher N, Ley D, et al.
Growth Horm IGF Res . 2017 Sep; 36:44-51. PMID: 28934640
Objective: To evaluate the feasibility of continuous longitudinal intravenous infusion of recombinant human insulin-like growth factor-1/recombinant human insulin-like growth factor binding protein-3 (rhIGF-1/rhIGFBP-3) for prevention of retinopathy of prematurity and...
27.
Chung J, Hallberg B, Hansen-Pupp I, Graham M, Fetterly G, Sharma J, et al.
Pediatr Res . 2016 Nov; 81(3):504-510. PMID: 27870826
Background: rhIGF-1/rhIGFBP-3 is being investigated for prevention of retinopathy of prematurity in extremely preterm infants. Methods: A population pharmacokinetic model was developed using data from phase I/II (Sections A-C) trials...
28.
Hellstrom A, Ley D, Hansen-Pupp I, Hallberg B, Ramenghi L, Lofqvist C, et al.
Growth Horm IGF Res . 2016 Oct; 30-31:75-80. PMID: 27720550
Retinopathy of prematurity is a potentially blinding disease, which is associated with low neonatal IGF-I serum concentrations and poor growth. In severe cases impaired retinal vessel growth is followed by...
29.
Hellstrom A, Ley D, Hansen-Pupp I, Hallberg B, Ramenghi L, Lofqvist C, et al.
Am J Perinatol . 2016 Sep; 33(11):1067-71. PMID: 27603537
The neonatal period of very preterm infants is often characterized by a difficult adjustment to extrauterine life, with an inadequate nutrient supply and insufficient levels of growth factors, resulting in...
30.
Hellstrom A, Ley D, Hansen-Pupp I, Hallberg B, Lofqvist C, Van Marter L, et al.
Acta Paediatr . 2016 Feb; 105(6):576-86. PMID: 26833743
Unlabelled: Poor postnatal growth after preterm birth does not match the normal rapid growth in utero and is associated with preterm morbidities. Insulin-like growth factor 1 (IGF-1) axis is the...